Key Market Indicators
Sales of digestive system disorder medicines in Hungary are on the rise and are projected to reach $381 million by 2026. In 2021, the country ranked 20th globally, with sales of $348 million. This represented a 6.1% year-on-year growth since 2004. Finland ranked ahead of Hungary, at $348.4 million, while Japan, South Korea and Canada came in at second, third and fourth, respectively.
